Article info
PDFClinical science
Ziv-aflibercept in macular disease
- Correspondence to Dr Ahmad Mansour, Department of Ophthalmology, American University of Beirut, Beirut 1136044, Lebanon; ammansourmd{at}gmail.com
Citation
Ziv-aflibercept in macular disease
Publication history
- Received October 26, 2014
- Revised January 5, 2015
- Accepted January 12, 2015
- First published February 12, 2015.
Online issue publication
August 17, 2018
Article Versions
- Previous version (17 August 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/